{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:42:20Z","timestamp":1790289740397,"version":"4.1.0"},"reference-count":154,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Schizophrenia is a severe mental disorder with a strong lifetime impact on patients\u2019 health and wellbeing. Usually, symptomatic treatment includes typical or atypical antipsychotics. Study findings show an involvement of low-grade inflammation (blood, brain parenchyma, and cerebrospinal fluid) in schizophrenia. Moreover, experimental and neuropathological evidence suggests that reactive microglia, which are the main resident immune cells of the central nervous system (CNS), have a negative impact on the differentiation and function of oligodendrocytes, glial progenitor cells, and astrocytes, which results in the disruption of neuronal networks and dysregulated synaptic transmission, contributing to the pathophysiology of schizophrenia. Here, the role of microglial cells related to neuroinflammation in schizophrenia was discussed to be essential. This review aims to summarize the evidence for the influence of antipsychotics on microglial inflammatory mechanisms in schizophrenia. Furthermore, we propose an established astrocyte\u2013microglia co-culture model for testing regulatory mechanisms and examining the effects of antipsychotics on glia-mediated neuroinflammation. This could lead to a better understanding of how typical and atypical antipsychotics can be used to address positive and negative symptoms in schizophrenia and comorbidities like inflammatory diseases or the status of low-grade inflammation.<\/jats:p>","DOI":"10.3389\/fpsyt.2025.1522128","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T07:04:11Z","timestamp":1742281451000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Influence of antipsychotic drugs on microglia-mediated neuroinflammation in schizophrenia: perspectives in an astrocyte\u2013microglia co-culture model"],"prefix":"10.3389","volume":"16","author":[{"given":"Timo Jendrik","family":"Faustmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Corvace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro M.","family":"Faustmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatme Seval","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","article-title":"Schizophrenia, \u201cjust the facts\u201d 4. Clinical features and conceptualization","volume":"110","author":"Tandon","year":"2009","journal-title":"Schizophr Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1212\/01.CON.0000466662.89908.e7","article-title":"Psychosis","volume":"21","author":"Arciniegas","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1801490","article-title":"Psychotic disorders","volume":"379","author":"Lieberman","year":"2018","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1086\/345442","article-title":"Association of neuregulin 1 with schizophrenia confirmed in a Scottish population","volume":"72","author":"Stefansson","year":"2003","journal-title":"Am J Hum Genet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2742","article-title":"Genome-wide association analysis identifies 13 new risk loci for schizophrenia","volume":"45","author":"Ripke","year":"2013","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102044","article-title":"Dysbindin-1 involvement in the etiology of schizophrenia","volume":"18","author":"Wang","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.282","article-title":"The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review","volume":"7","author":"Dahoun","year":"2017","journal-title":"Transl Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2013the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr Bull"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107426","article-title":"The origin of NMDA receptor hypofunction in schizophrenia","volume":"205","author":"Nakazawa","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J Psychiatr Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12823","article-title":"Glutamate hypothesis in schizophrenia","volume":"73","author":"Uno","year":"2019","journal-title":"Psychiatry Clin Neurosci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.22541\/au.172646104.48099324\/v1","article-title":"Differential protective effects of typical versus atypical antipsychotic drugs in a phencyclidine microelectrode array model of schizophrenia","author":"Faustmann","year":"2024","journal-title":"Authorea (Preprint)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0572-3","article-title":"Acute and chronic effects of ketamine upon human memory: a review","volume":"188","author":"Morgan","year":"2006","journal-title":"Psychopharmacol (Berl)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41537-024-00485-x","article-title":"Advances in the study of phencyclidine-induced schizophrenia-like animal models and the underlying neural mechanisms","volume":"10","author":"Li","year":"2024","journal-title":"Schizophr (Heidelb)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1208494109","article-title":"NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia","volume":"109","author":"Anticevic","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.01.022","article-title":"GABAergic interneuron origin of schizophrenia pathophysiology","volume":"62","author":"Nakazawa","year":"2012","journal-title":"Neuropharmacology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060947","article-title":"Brain NMDA receptors in schizophrenia and depression","volume":"10","author":"Adell","year":"2020","journal-title":"Biomolecules"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1335253","article-title":"Schizophrenia\u2013a mild encephalitis]","volume":"81","author":"Bechter","year":"2013","journal-title":"Fortschr Neurol Psychiatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am J Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1176\/appi.ajp.2007.07050740","article-title":"Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects","volume":"165","author":"Dalman","year":"2008","journal-title":"Am J Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300217","article-title":"Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype","volume":"28","author":"Garver","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0220-4","article-title":"Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis","volume":"24","author":"Orlovska-Waast","year":"2019","journal-title":"Mol Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2022.110697","article-title":"Social interaction, psychotic disorders and inflammation: A triangle of interest","volume":"122","author":"Faustmann","year":"2023","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000511552","article-title":"The role of brain microvascular endothelial cell and blood-brain barrier dysfunction in schizophrenia","volume":"6","author":"Pong","year":"2020","journal-title":"Complex Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"van Os","year":"2009","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn187","article-title":"The neurodevelopmental hypothesis of schizophrenia, revisited","volume":"35","author":"Fatemi","year":"2009","journal-title":"Schizophr Bull"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00274","article-title":"Childhood trauma in schizophrenia: current findings and research perspectives","volume":"13","author":"Popovic","year":"2019","journal-title":"Front Neurosci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn101","article-title":"Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction","volume":"34","author":"van Winkel","year":"2008","journal-title":"Schizophr Bull"},{"key":"B34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.comppsych.2015.12.003","article-title":"Childhood traumatic events and types of auditory verbal hallucinations in first-episode schizophrenia patients","volume":"66","author":"Misiak","year":"2016","journal-title":"Compr Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00024","article-title":"Glial cells and their function in the adult brain: A journey through the history of their ablation","volume":"11","author":"Jakel","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.90","article-title":"Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review","volume":"21","author":"Trepanier","year":"2016","journal-title":"Mol Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: Microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5498\/wjp.v8.i2.51","article-title":"Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders","volume":"8","author":"Parkin","year":"2018","journal-title":"World J Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2012.12.019","article-title":"Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia","volume":"144","author":"Shan","year":"2013","journal-title":"Schizophr Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2009.07.025","article-title":"Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia","volume":"117","author":"Bauer","year":"2010","journal-title":"Schizophr Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2021.10.012","article-title":"Astrocytes render memory flexible by releasing D-serine and regulating NMDA receptor tone in the hippocampus","volume":"91","author":"Koh","year":"2022","journal-title":"Biol Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.6.572","article-title":"Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia","volume":"60","author":"Hashimoto","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00544","article-title":"Astrocytic regulation of glutamate transmission in schizophrenia","volume":"9","author":"Mei","year":"2018","journal-title":"Front Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0140-6736(03)14289-4","article-title":"Oligodendrocyte dysfunction in schizophrenia and bipolar disorder","volume":"362","author":"Tkachev","year":"2003","journal-title":"Lancet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.5.443","article-title":"White matter changes in schizophrenia: evidence for myelin-related dysfunction","volume":"60","author":"Davis","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.05.009.2009","article-title":"Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex","volume":"3","author":"Hoistad","year":"2009","journal-title":"Front Neuroanat"},{"key":"B47","doi-asserted-by":"publisher","first-page":"15034","DOI":"10.1038\/npjschz.2015.34","article-title":"Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules","volume":"1","author":"Cassoli","year":"2015","journal-title":"NPJ Schizophr"},{"key":"B48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pneurobio.2010.09.004","article-title":"Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia","volume":"93","author":"Takahashi","year":"2011","journal-title":"Prog Neurobiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1159\/000346157","article-title":"Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia","volume":"35","author":"Chew","year":"2013","journal-title":"Dev Neurosci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.09.011","article-title":"Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-gamma-stimulated microglia in co-culture model","volume":"151","author":"Seki","year":"2013","journal-title":"Schizophr Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.12.023","article-title":"Microglia: new roles for the synaptic stripper","volume":"77","author":"Kettenmann","year":"2013","journal-title":"Neuron"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13003","article-title":"Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between brain regions","volume":"32","author":"Gober","year":"2022","journal-title":"Brain Pathol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.110","article-title":"Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia","volume":"18","author":"Fillman","year":"2013","journal-title":"Mol Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3940(99)00545-5","article-title":"Evidence for activation of microglia in patients with psychiatric illnesses","volume":"271","author":"Bayer","year":"1999","journal-title":"Neurosci Lett"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2012.08.005","article-title":"Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations","volume":"26","author":"Busse","year":"2012","journal-title":"Brain Behav Immun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.05219.x","article-title":"Calprotectin in microglia from frontal cortex is up-regulated in schizophrenia: evidence for an inflammatory process","volume":"24","author":"Foster","year":"2006","journal-title":"Eur J Neurosci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23962","article-title":"A loss of mature microglial markers without immune activation in schizophrenia","volume":"69","author":"Snijders","year":"2021","journal-title":"Glia"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02529-1","article-title":"Genetic contribution to microglial activation in schizophrenia","volume":"29","author":"Koskuvi","year":"2024","journal-title":"Mol Psychiatry"},{"key":"B60","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","article-title":"Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study","volume":"173","author":"Bloomfield","year":"2016","journal-title":"Am J Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study","volume":"64","author":"van Berckel","year":"2008","journal-title":"Biol Psychiatry"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2019.10.045","article-title":"Microglial activation in schizophrenia: Is translocator 18kDa protein (TSPO) the right marker","volume":"215","author":"Sneeboer","year":"2020","journal-title":"Schizophr Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16020171","article-title":"Imaging microglial activation in untreated first-episode psychosis: A PET study with [(18)F]FEPPA","volume":"174","author":"Hafizi","year":"2017","journal-title":"Am J Psychiatry"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-55529-9_32","article-title":"Microglial positron emission tomography imaging in vivo: positron emission tomography radioligands: utility in research and clinical practice","volume":"37","author":"Ottoy","year":"2024","journal-title":"Adv Neurobiol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1345349","article-title":"Microglia-neuron interactions in schizophrenia","volume":"18","author":"Hartmann","year":"2024","journal-title":"Front Cell Neurosci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.180","article-title":"In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [(11)C](R)-PK11195 positron emission tomography study","volume":"21","author":"Holmes","year":"2016","journal-title":"Mol Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol Psychiatry"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717000745","article-title":"Immunopsychiatry: important facts","volume":"47","author":"Khandaker","year":"2017","journal-title":"Psychol Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations","volume":"44","author":"Muller","year":"2018","journal-title":"Schizophr Bull"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-018-0334-7","article-title":"Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning","volume":"22","author":"Sellgren","year":"2019","journal-title":"Nat Neurosci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02043-w","article-title":"The synaptic hypothesis of schizophrenia version III: a master mechanism","volume":"28","author":"Howes","year":"2023","journal-title":"Mol Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e3000604","DOI":"10.1371\/journal.pbio.3000604","article-title":"Increased expression of schizophrenia-associated gene C4 leads to hypoconnectivity of prefrontal cortex and reduced social interaction","volume":"18","author":"Comer","year":"2020","journal-title":"PloS Biol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01081-6","article-title":"Elevated expression of complement C4 in the mouse prefrontal cortex causes schizophrenia-associated phenotypes","volume":"26","author":"Druart","year":"2021","journal-title":"Mol Psychiatry"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2006.10.013","article-title":"Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide","volume":"42","author":"Steiner","year":"2008","journal-title":"J Psychiatr Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.2174\/18715273113129990099","article-title":"Possible impact of microglial cells and the monocyte-macrophage system on suicidal behavior","volume":"12","author":"Steiner","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.08.014.2009","article-title":"Early-life programming of later-life brain and behavior: a critical role for the immune system","volume":"3","author":"Bilbo","year":"2009","journal-title":"Front Behav Neurosci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3688-11.2011","article-title":"Microglia and memory: modulation by early-life infection","volume":"31","author":"Williamson","year":"2011","journal-title":"J Neurosci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B80","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41537-023-00370-z","article-title":"Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions","volume":"9","author":"Zhuo","year":"2023","journal-title":"Schizophr (Heidelb)"},{"key":"B81","doi-asserted-by":"publisher","first-page":"795","DOI":"10.11477\/mf.1416201837","article-title":"Stress mediated microglial hyper-activation and psychiatric diseases","volume":"73","author":"Enomoto","year":"2021","journal-title":"Brain Nerve"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ajp.2014.08.002","article-title":"Antipsychotic treatment of schizophrenia: an update","volume":"11","author":"Bruijnzeel","year":"2014","journal-title":"Asian J Psychiatr"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00366-8","article-title":"Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data","volume":"11","author":"Efthimiou","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1055\/a-2029-6387","article-title":"Antipsychotic treatment of alcohol withdrawal syndrome with focus on delirium tremens: a systematic review","author":"Faustmann","year":"2023","journal-title":"Fortschr Neurol Psychiatr"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"B86","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu Rev Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.6.751","article-title":"Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome","volume":"155","author":"Buchanan","year":"1998","journal-title":"Am J Psychiatry"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(94)90032-9","article-title":"Positive versus negative symptoms in schizophrenia: response to haloperidol","volume":"18","author":"Palao","year":"1994","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2174\/138955711795906941","article-title":"Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a \u2018fire extinguisher\u2019 in the brain of schizophrenia","volume":"11","author":"Kato","year":"2011","journal-title":"Mini Rev Med Chem"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2012.10.022","article-title":"The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia","volume":"48","author":"Na","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911324","article-title":"Cytokine imbalance as a biomarker of treatment-resistant schizophrenia","volume":"23","author":"Shnayder","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyy062","article-title":"Kinetics of cytokine levels during antipsychotic treatment in schizophrenia: A meta-analysis","volume":"21","author":"Romeo","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0829-y","article-title":"Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis","volume":"26","author":"Conen","year":"2021","journal-title":"Mol Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.193","article-title":"PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia","volume":"7","author":"Di Biase","year":"2017","journal-title":"Transl Psychiatry"},{"key":"B95","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.euroneuro.2007.04.005","article-title":"The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production","volume":"18","author":"Danovich","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00765-x","article-title":"Effects of antipsychotic drugs: cross talk between the nervous and innate immune system","volume":"34","author":"Dinesh","year":"2020","journal-title":"CNS Drugs"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2015.08.004","article-title":"Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses","volume":"25","author":"Cotel","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002139900333","article-title":"Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels","volume":"149","author":"Fitzgerald","year":"2000","journal-title":"Psychopharmacol (Berl)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094399","article-title":"Effects of haloperidol, risperidone, and aripiprazole on the immunometabolic properties of BV-2 microglial cells","volume":"22","author":"Racki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.32598\/bcn.11.1.1272.1","article-title":"Haloperidol\u2019s effect on the expressions of TGFB, NT-3, and BDNF genes in cultured rat microglia","volume":"11","author":"Namjoo","year":"2020","journal-title":"Basic Clin Neurosci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118788830","article-title":"The effects of haloperidol on microglial morphology and translocator protein levels: An in vivo study in rats using an automated cell evaluation pipeline","volume":"32","author":"Bloomfield","year":"2018","journal-title":"J Psychopharmacol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1996.0022","article-title":"Haloperidol prevents ketamine- and phencyclidine-induced HSP70 protein expression but not microglial activation","volume":"137","author":"Nakki","year":"1996","journal-title":"Exp Neurol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135976","article-title":"A high-fat diet, but not haloperidol or olanzapine administration, increases activated microglial expression in the rat brain","volume":"757","author":"Maredia","year":"2021","journal-title":"Neurosci Lett"},{"key":"B104","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s12888-023-05014-1","article-title":"Minocycline and antipsychotics inhibit inflammatory responses in BV-2 microglia activated by LPS via regulating the MAPKs\/JAK-STAT signaling pathway","volume":"23","author":"Long","year":"2023","journal-title":"BMC Psychiatry"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.05.049","article-title":"Antipsychotics, chlorpromazine and haloperidol inhibit voltage-gated proton currents in BV2 microglial cells","volume":"738","author":"Shin","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.euroneuro.2004.04.002","article-title":"Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures","volume":"15","author":"Labuzek","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24629","article-title":"The antipsychotic chlorpromazine reduces neuroinflammation by inhibiting microglial voltage-gated potassium channels","volume":"73","author":"Lee","year":"2025","journal-title":"Glia"},{"key":"B108","article-title":"Flupentixol and trifluperidol reduce interleukin-1 beta and interleukin-2 release by rat mixed glial and microglial cell cultures","volume":"56","author":"Kowalski","year":"2004","journal-title":"Pol J Pharmacol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/s0197-0186(02)00163-8","article-title":"Flupentixol and trifluperidol reduce secretion of tumor necrosis factor-alpha and nitric oxide by rat microglial cells","volume":"43","author":"Kowalski","year":"2003","journal-title":"Neurochem Int"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05675.x","article-title":"The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production","volume":"107","author":"Zheng","year":"2008","journal-title":"J Neurochem"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(08)00909-6","article-title":"In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems","volume":"172","author":"Meltzer","year":"2008","journal-title":"Prog Brain Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656941","article-title":"Clozapine regulates microglia and is effective in chronic experimental autoimmune encephalomyelitis","volume":"12","author":"Ceylan","year":"2021","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030577","article-title":"Clozapine prevents poly (I:C) induced inflammation by modulating NLRP3 pathway in microglial cells","volume":"9","author":"Giridharan","year":"2020","journal-title":"Cells"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.04.012","article-title":"Clozapine reduces Toll-like receptor 4\/NF-kappaB-mediated inflammatory responses through inhibition of calcium\/calmodulin-dependent Akt activation in microglia","volume":"81","author":"Jeon","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B115","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11481-011-9309-0","article-title":"Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation","volume":"7","author":"Hu","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.03.003","article-title":"Clozapine and olanzapine inhibit proton currents in BV2 microglial cells","volume":"755","author":"Shin","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2165\/00023210-200216110-00008","article-title":"Aripiprazole","volume":"16","author":"McGavin","year":"2002","journal-title":"CNS Drugs"},{"key":"B118","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.schres.2016.08.022","article-title":"Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7","volume":"178","author":"Sato-Kasai","year":"2016","journal-title":"Schizophr Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05435.x","article-title":"Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro","volume":"106","author":"Kato","year":"2008","journal-title":"J Neurochem"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.06.031","article-title":"The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma","volume":"32","author":"Bian","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu022","article-title":"Quetiapine attenuates glial activation and proinflammatory cytokines in APP\/PS1 transgenic mice via inhibition of nuclear factor-kappaB pathway","volume":"18","author":"Zhu","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00492","article-title":"Quetiapine inhibits microglial activation by neutralizing abnormal STIM1-mediated intercellular calcium homeostasis and promotes myelin repair in a cuprizone-induced mouse model of demyelination","volume":"9","author":"Wang","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.01.019","article-title":"Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro","volume":"92","author":"Kato","year":"2007","journal-title":"Schizophr Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.05.006","article-title":"Effects of clozapine, olanzapine and haloperidol on nitric oxide production by lipopolysaccharide-activated N9 cells","volume":"30","author":"Hou","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B125","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jneuroim.2004.02.006","article-title":"Sodium butyrate suppresses interferon-gamma-, but not lipopolysaccharide-mediated induction of nitric oxide and tumor necrosis factor-alpha in microglia","volume":"151","author":"Kim","year":"2004","journal-title":"J Neuroimmunol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2005.07.003","article-title":"Repression of interferon-gamma-induced inducible nitric oxide synthase (iNOS) gene expression in microglia by sodium butyrate is mediated through specific inhibition of ERK signaling pathways","volume":"168","author":"Park","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/s0165-0173(03)00203-0","article-title":"Calcium signaling dysfunction in schizophrenia: a unifying approach","volume":"43","author":"Lidow","year":"2003","journal-title":"Brain Res Brain Res Rev"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2021.09.023","article-title":"The emerging tale of microglia in psychiatric disorders","volume":"131","author":"Rahimian","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.2174\/0929867311320030003","article-title":"Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry","volume":"20","author":"Kato","year":"2013","journal-title":"Curr Med Chem"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(17)30101-3","article-title":"Brain microglia in psychiatric disorders","volume":"4","author":"Mondelli","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1177\/15353702231222027","article-title":"The Janus face of antipsychotics in glial cells: Focus on glioprotection","volume":"248","author":"Schmitz","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/glia.10141","article-title":"Microglia activation influences dye coupling and Cx43 expression of the astrocytic network","volume":"42","author":"Faustmann","year":"2003","journal-title":"Glia"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.805755","article-title":"Pharmacological investigations in glia culture model of inflammation","volume":"15","author":"Ismail","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"B134","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/glia.20223","article-title":"Effects of cytokines on microglial phenotypes and astroglial coupling in an inflammatory coculture model","volume":"52","author":"Hinkerohe","year":"2005","journal-title":"Glia"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115623","article-title":"Effects of atypical antipsychotics, clozapine, quetiapine and brexpiprazole on astroglial transmission associated with connexin43","volume":"22","author":"Fukuyama","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00186","article-title":"Influence of drugs on gap junctions in glioma cell lines and primary astrocytes in vitro","volume":"5","author":"Moinfar","year":"2014","journal-title":"Front Physiol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.05.016","article-title":"Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats","volume":"104","author":"Fatemi","year":"2008","journal-title":"Schizophr Res"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02861-6","article-title":"Glial cell deficits are a key feature of schizophrenia: implications for neuronal circuit maintenance and histological differentiation from classical neurodegeneration","author":"Bernstein","year":"2024","journal-title":"Mol Psychiatry"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174696","article-title":"Anti-inflammatory properties of lacosamide in an astrocyte-microglia co-culture model of inflammation","volume":"915","author":"Corvace","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21639","article-title":"Implications of antiinflammatory properties of the anticonvulsant drug levetiracetam in astrocytes","volume":"86","author":"Haghikia","year":"2008","journal-title":"J Neurosci Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145707007729","article-title":"Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model","volume":"11","author":"Vollmar","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1476-5381.2010.01038.x","article-title":"Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFbeta1 regulation","volume":"162","author":"Stienen","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12473","article-title":"Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia\/microglia co-culture model of inflammation","volume":"55","author":"Dambach","year":"2014","journal-title":"Epilepsia"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyab080","article-title":"Effects of lamotrigine and topiramate on glial properties in an astrocyte-microglia co-culture model of inflammation","volume":"25","author":"Faustmann","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.995861","article-title":"Brivaracetam exhibits mild pro-inflammatory features in an in vitro astrocyte-microglia co-culture model of inflammation","volume":"16","author":"Ismail","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13030493","article-title":"Inhibition of microglial activation by amitriptyline and doxepin in interferon-beta pre-treated astrocyte-microglia co-culture model of inflammation","volume":"13","author":"Faustmann","year":"2023","journal-title":"Brain Sci"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02538-x","article-title":"Tiagabine and zonisamide differentially regulate the glial properties in an astrocyte-microglia co-culture model of inflammation","volume":"396","author":"Ismail","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30302-5","article-title":"Glial cells in schizophrenia: a unified hypothesis","volume":"7","author":"Dietz","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"B150","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.08.021","article-title":"Alzheimer\u2019s disease: From immunotherapy to immunoprevention","volume":"186","author":"Jucker","year":"2023","journal-title":"Cell"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad005","article-title":"Anti-amyloid antibody therapies in Alzheimer\u2019s disease","volume":"146","author":"Perneczky","year":"2023","journal-title":"Brain"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2016.01.003","article-title":"The case for adjunctive monoclonal antibody immunotherapy in schizophrenia","volume":"39","author":"Miller","year":"2016","journal-title":"Psychiatr Clin North Am"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1522128\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T07:04:18Z","timestamp":1742281458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1522128\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":154,"alternative-id":["10.3389\/fpsyt.2025.1522128"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1522128","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"article-number":"1522128"}}